Clinical efficacy of EH0202, a Kampo formula, on the health of middle-aged women

American Journal of Chinese Medicine

Volumn 32, Issue 5, 2004, Pages 755-770

  Ushiroyama, Takahisa ^a   Yoshida, Satoshi ^b   Tadaki, Keiichi ^c   Ikeda, Atsushi ^a   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c Marketing Division   (Japan)

Author keywords

Blood pressure; EH0202 (MACH); Lipid metabolism; Peri and post menopausal women; Skin surface blood flow

Indexed keywords

CARTHAMUS TINCTORIUS EXTRACT; CUCURBITA MOSCHATA EXTRACT; HERBACEOUS AGENT; INTERPUNCH; KAMPO; LACTULOSE; LIPID; LONICERA JAPONICA EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; PLANTAGO ASIATICA EXTRACT; PREBIOTIC AGENT; PROBIOTIC AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; EH0202;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHINESE HERB; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CUCURBITA MOSCHATA; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FLUSHING; HEALTH STATUS; HUMAN; LIPID BLOOD LEVEL; LONICERA; LONICERA JAPONICA; MACROPHAGE ACTIVATION; MENOPAUSAL SYNDROME; PLANTAGO; PLANTAGO ASIATICA; POSTMENOPAUSE; QUALITY OF LIFE; RATING SCALE; SKIN BLOOD FLOW; SKIN SURFACE; SQUASH; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL ANALOG SCALE; AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS; CHINESE MEDICINE; CLINICAL TRIAL; DRUG EFFECT; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, LDL; FEMALE; HUMANS; MEDICINE, KAMPO; MIDDLE AGED; PLANT EXTRACTS; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 21744456426     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X04002314     Document Type: Article

References (54)

1. Abe, T., M. Suzuki, T. Moritsuka and Y. Botan. Statistical factor analysis and cluster analysis in the aetiology of climacteric symptoms. Tohoku J. Exp. Med. 143: 481-489, 1984.
2. Albretazzi, P., F. Pansini, M. Bottazzi, G. Bonaccorsi, D. De Aloysio and M.S. Morton. Phytoestrogen levels and the climacterium: Effects of a diet supplemented with soy. Obstet. Gynecol. 94: 229-231, 1999.
3. Allain, C.C., L.S. Poon, C.S.G. Chan, W. Richmond and P.C. Fu. Enzymatic determination of total serum cholesterol. Clin. Chem. 20: 470-475, 1974.
4. American College of Obstetricians and Gynecologists Committee on Practice Bulletins (ACOG Practice Bulletin). Clinical management guidelines for Obstetrician-Gynecologists. Use of botanicals for management of menopausal symptoms. Obstet. Gynecol. 97 (Suppl.): 1-11, 2001.
5. Bucolo, G. and H. David. Quantitative determination of serum triglyceride by the use of enzyme. Clin. Chem. 19: 476-482, 1973.
6. Cengiz, B., C. Atabekoglu, E. Cetinkaya and S.D. Cengiz. Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopusal women. Maturitas 46: 301-306, 2003.
7. Chansue, N., A. Ponpornpisit, M. Endo, M. Sakai and S. Yoshida. Improved immunity of Tilapia Oreochromis niloticus by C-UP, a herb medicine. Fish Pathol. 35: 89-90. Biological Abstracts AA-200000383054, 2000.
8. Ewies, A.A. A comprehensive approach to the menopause: So far, one size should fit all. Obstet. Gynecol. Surv. 56: 642-649, 2001.
9. Friedewald, W.T., R.I. Levy and D.S. Frederikson. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502, 1972.
10. Gambacciani, M., M. Ciaponi, B. Cappagli, P. Monteleone, C. Benussi, G. Bevilacqua and A.R. Genazzani. Postmenopausal femur bone loss: Effects of a low dose hormone replacement therapy. Maturitas 45: 175-183, 2003.
11. Greene, J.G. A factor analytic study of climacteric symptoms. J. Psychosom. Res. 20: 425-430, 1976.
12. Greene, J.G. Constructing a standard climacteric scale. Maturitas 29: 25-31, 1998.
13. Haines, C.J., S.F. Yim, T.K.H. Chung, C.W.K. Lam, E.W.C. Lau, M.H.L. Ng, R. Chin and D.T.S. Lee. A prospective, randomized, placebo-controlled study of the dose effect of oral estradiol on bone mineral density in postmenopausal Chinese women. Maturitas 45: 169-173, 2003.
14. Holmberg, L. and H. Anderson. HABITS (hormone replacement therapy after breast cancer - is it safe?), a randomized comparison: Trial stopped. Lancet 363: 453-455, 2004.
15. Holte, A. and A. Mikkelsen. The menopausal syndrome; a factor analytic replication. Maturitas 13: 193-203, 1991.
16. Hulley, S., D. Grady and T. Bush. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613, 1998.
17. Hunter, M., R. Battersby and M. Whitehead. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 8: 217-228, 1986.
18. Indira, S.N. and V.N. Murthy. A factor analytic study of menopausal symptoms in middle aged women. Indian J. Clin. Psychol. 7: 125-128, 1980.
19. Jacobs, P.A. and M.E. Hyland. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs. Maturitas 46: 273-281, 2003.
20. Kagaya, A., A. Kugaya, M. Takebayashi, M. Fukue-Saeki, T. Saeki, S. Yamawaki and Y. Uchitomi. Plasma concentrations of interleukin-1 beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressive patients in Japan. Neuropsychobiology 43: 59-62, 2001.
21. Kanba, S, K. Yamada, H. Mizushima and M. Asai. Use of herbal medicine for treating psychiatric disorders in Japan. Psychiatr. Clin. Neurosci. 52 (Suppl.): S331-333, 1998.
22. Kaufert, P. and J. Syrotuik. Symptom reporting at the menopause. Soc. Sci. Med. 15: 173-184, 1981.
23. Kojima, Y. Kampo medicines and interferon inducers. Kampo Med. 5: 9-15, 1981 (in Japanese).
24. Kronenberg, F. and A. Fugh-Berman. Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann. Intern. Med. 137: 805-813, 2002.
25. Lerner, J.H. TCM/Kampo therapy also efficacious for menopause. Altern. Ther. Health. Med. 7: 21, 2001.
26. Lutgendorf, S.K., L. Garand, K.C. Buckwalter, T.T. Reimer, S.Y. Hong and D.M. Lubaroff. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J. Gerontol. A. Biol. Sci. Med. Sci. 54: M434-439, 1999.
27. Mantani, N, A. Hisanaga, T. Kogure, T. Kita, Y. Shimada and K. Terasawa. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kami-shoyo-san and Hange-koboku-to. Psychiatr. Clin. Neurosci. 56: 1323-1316, 2002.
28. Marcozzi, G., V. Liberati, F. Madia, A. Pizzinga and G. de Feo. Effect of hormone replacement therapy on lacrimal fluid peroxidase activity in woman. Maturitas 45: 225-229, 2003.
29. Marx, P., G. Schade, S. Wilbourn, S. Blank, D.L. Moyer and R. Nett. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis. Maturitas 47: 47-54, 2004.
30. McCoy, N.L. Methodological problems in the study of sexuality and the menopause. Maturitas 29: 51-60, 1998.
31. Mikkelsen, A. and A. Holte. A factor analytic study of climacteric symptoms. Psychiatr. Soc. Sci. 2: 35-39, 1982.
32. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427, 2003.
33. Ponpornpisit, A., M. Endo and H. Murata. Prophyylactic effects of chemicals and immunostimulants in experimental Tetrahymena infections of guppy. Fish Pathol. 36: 1-6, 2001.
34. Reichenberg, A., R. Yirmiya, A. Schuld, T. Kraus, M. Haack, A. Morag and T. Pollmacher. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatr. 58: 445-452, 2001.
35. Richardson, M.A. Biopharmacologic and herbal therapies for cancer: research update from NCCAM. J. Nutr. 131 (Suppl.): 3037S-3040S, 2001.
36. Russel, L., G.S. Hicks, A.K. Low, J.M. Shepherd and C.A. Brown. Phytoestrogens: A viable option? Am. J. Med. Sci. 324: 185-188, 2002.
37. Slopien, R., R. Junik, B. Meczekalski, B. Halerz-Nowakowska, M. Maciejewska, A. Warenik-Szymankiewicz and J. Sowinski. Influence of hormone replacement therapy on the regional cerebral blood flow in postmenopausal women. Maturitas 46: 255-262, 2003.
38. Song, Q.H., K. Toriizuka, K. Iijima, T. Yabe, T. Yokozawa and J.C. Cyong. Effects of Hokoei-to (pugongying-tang), a Kampo formula, on monoamine content in brain regions and mitogenic activity of splenic lymphocytes in ovariectomized mice. Am. J. Chin. Med. 29: 433-443, 2001.
39. Takeishi, M., S. Shimizu, K. Tsumagari, A. Kinoshita, S. Yoshida and E. Momotani. Studies on efficacy of the herbal MACH on IgE, interferon and intra-peritoneal macrophage in mice. In: The Proceedings of the 4th Advanced Traditional Chinese Veterinary Medicine Seminar. Chi Institute, Florida, USA, 2000, pp. 85-102.
40. Talameh, Y., R. Wei and H. Naito. Measurements of total HDL, HDL2, HDL3 by dextran sulfate-MgC12 precipitation technique in human serum. Clin. Chem. Acta 158: 33-39, 1986.
41. Teede, H.J. Controversies in HRT. Aust. Fam. Physician 31: 413-418, 2002.
42. Terasawa, K. OKETSU (blood stasis). KAMPO - Japanese Oriental Medicine K.K. STANDARD McINTYPE, Tokyo, 1993, pp. 43-51.
43. Thomsen, A.B., S. Silvestri, J. Haarbo, C. Christiansen and N.H. Bjarnason. Associated response in bone and lipids during hormone replacement therapy. Maturitas 47: 39-45, 2004.
44. Toriizuka, K., P. Hou, T. Yabe, K. Iijima, T. Hanawa and J.C. Cyong. Effects of Kampo medicine, Toki-shakuyaku-san (Tang-Kuei-Shao-Yao-San), on choline acethyltransferase activity and norepinephrine contents in brain regions, and mitogenic activity of splenic lymphocytes in ovariectomized mice. J. Ethnopharmacol. 71: 133-143, 2000.
45. Toriumi, H., Y. Ichikawa, T. Terao, K. Yamagiwa, K. Shimizu and M. Takeishi. Clinical efficacy of the feed additive MACH on the incidence of respiratory diseases in piglets. In: The Proceedings of Guangzhou International Conference on the Advanced Traditional Chinese Veterinary Medicine 2000. Chi Institute, Florida, USA, 2000, pp. 193-196.
46. Ushiroyama, T. Optimal treatment of menopausal disorders based on differential diagnosis from mental disorders. In: T. Aso, T. Yanaihara and S. Fujimoto (eds.) The Menopause at the Millennium. Parthenon Publishing, New York, London, 2000, pp. 256-264.
47. Ushiroyama, T., A. Ikeda and M. Ueki. Elevated plasma interleukin-6 (IL-6) and soluble IL-6 receptor concentrations in menopausal women with and without depression. Int. J. Gynecol. Obstet. 79: 51-52, 2002.
48. Ushiroyama, T., A. Ikeda and M. Ueki. Kami-shoyo-san, a herbal medicine, reduces plasma interleukin-6 (IL-6) and soluble IL-6 receptor concentrations in depressed climacteric women. J. Tradit. Med. 4: 150-155, 2003.
49. Watanabe, H., T. Kobayashi, M. Tomii, Y. Sekiguchi, K. Uchida, T. Aoki and J.C. Cyong. Effects of Kampo herbal medicine on plasma melatonin concentration in patients. Am. J. Chin. Med. 30: 65-71, 2002.
50. Wiseman, N. and A. Ellis. Pathologies of the blood. In: N. Wiseman and A. Ellis (eds.) Fundamentals of Chinese Medicine. Paradigm Publications, Blookline, Massachusetts, 1996, pp. 22-23.
51. Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321-333, 2002.
52. Yilmazer, M., V. Fenkci, S. Fenkci, M. Sonmezer, O. Aktepe, M. Altindis and G. Kurtay. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. Maturitas 46: 245-253, 2003.
53. Yoshida, M., K. Tanemura, A. Wakabayashi, Y. Otsuka, S. Yoshida and E. Onda. Study of therapeutic effect of plant complex feed C-UP III on subclinical mastitis caused by S. aureus in daily cows and activation of blood macrophages. In: The Proceedings of Pacific Congress on Milk Quality and Mastitis Control. Organizing Committee of the Pacific Congress on Milk Quality and Mastitis Control, Nagoya, Japan, 2000, pp. 547-552.
54. Yu, C.M., J.C. Chan and J.C. Sanderson. Chinese herbs and warfarin potentiation by "anshen". J. Intern. Med. 241: 337-339, 1997.